drugset

drugset / Trial / NCT00769496

BAY 77-1931 Long-term Extension From Phase II Study

NCT00769496 ↗

Phase 2 Completed 145 enrolled Bayer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

A long-term study of BAY77-1931 (lanthanum carbonate) for hyperphosphatemia in patients undergoing hemodialysis

Timeline

Start: 2005-01
Primary completion: 2008-05
Completion: 2008-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lanthanum Carbonate	Other / unclassified	—	—

Indications